High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway

Hypertens Res. 2014 Jan;37(1):13-8. doi: 10.1038/hr.2013.108. Epub 2013 Sep 12.

Abstract

Angiotensin II (Ang II)-induced vascular injury is exacerbated by high-salt diets. This study examined the effects of high-sodium level on Ang II-induced cell proliferation in rat vascular smooth muscle cells (VSMCs). The cells were cultured in a standard medium containing 137.5 mmol l(-1) of sodium. The high-sodium medium (140 mmol l(-1)) contained additional sodium chloride. Extracellular signal-regulated kinase (ERK) 1/2 phosphorylation was determined by western blot analysis. Cell proliferation was evaluated by [(3)H]-thymidine incorporation. Ang II (100 nmol l(-1)) significantly increased ERK 1/2 phosphorylation and cell proliferation in the both medium containing standard sodium and high sodium. High-sodium level augmented Ang II-induced ERK 1/2 phosphorylation and cell proliferation compared with standard sodium. Pre-treatment with candesartan (1 μmol l(-1), Ang II type 1 receptor blocker) or PD98095 (10 μmol l(-1), ERK kinase iinhibitor) abolished the proliferative effect induced by high sodium/Ang II. Pre-treatment with 5-N,N-hexamethylene amiloride (30 μmol l(-1), Na(+)/H(+) exchanger type 1 (NHE-1) inhibitor), but not SN-6 (10 μmol l(-1), Na(+)/Ca(2+) exchanger inhibitor) or ouabain (1 mmol l(-1), Na(+)/K(+)-ATPase inhibitor) attenuated ERK 1/2 phosphorylation or cell proliferation. Osmotic pressure or chloride had no effect on Ang II-induced proliferative changes. High-sodium level did not affect Ang II receptor expression. Ang II increased intracellular pH via NHE-1 activation, and high-sodium level augmented the pH increase induced by Ang II. These data suggest that high-sodium level directly augments Ang II-induced VSMC proliferation through NHE-1- and ERK 1/2-dependent pathways and may offer new insights into the mechanisms of vascular remodeling by high-sodium/Ang II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Aorta, Thoracic / drug effects
  • Atherosclerosis / chemically induced
  • Atherosclerosis / pathology
  • Blotting, Western
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Chlorides / pharmacology
  • Culture Media
  • Hydrogen-Ion Concentration
  • Immunoprecipitation
  • MAP Kinase Signaling System / drug effects*
  • Male
  • Muscle, Smooth, Vascular / cytology*
  • Muscle, Smooth, Vascular / drug effects
  • Myocytes, Smooth Muscle / drug effects*
  • Osmolar Concentration
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction
  • Receptor, Angiotensin, Type 1 / drug effects
  • Sodium / pharmacology*
  • Sodium Channels / drug effects
  • Sodium Channels / physiology
  • Thymidine / metabolism
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Chlorides
  • Culture Media
  • Receptor, Angiotensin, Type 1
  • Sodium Channels
  • Vasoconstrictor Agents
  • Angiotensin II
  • Sodium
  • Thymidine